Application of direct crystallization for racemic compound propranolol hydrochloride

Journal of Pharmaceutical Sciences

Volumn 96, Issue 10, 2007, Pages 2735-2745

  Wang, Xiujuan ^a   Lu, Jie ^a   Chi, Bun Ching ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Direct crystallization; DSC; FBRM; HPLC; Metastable zone width; Optical purity; Racemic compound; Solubility

Indexed keywords

2 PROPANOL; METHANOL; PROPRANOLOL;

ANALYTIC METHOD; ARTICLE; CHROMATOGRAPHY; CRYSTAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PURITY; DRUG SOLUBILITY; DRUG STABILITY; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; MORPHOLOGY; PARTICLE SIZE; RACEMIC MIXTURE; REACTOR; REFLECTOMETRY; TEMPERATURE DEPENDENCE; X RAY DIFFRACTION;

EID: 35348940741     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20911     Document Type: Article

References (27)

1. Jacques J, Collet A, Willen SH. 1981. Enantiomers, racemates, and resolution. New York: John Wiley and Sons.
2. Sheldon RA. 1993. Chirotechnology - industrial synthesis of optical active compounds. New York: Marcel Dekker, Inc.
3. Collet A, Brienne MJ, Jacques J. 1980. Optical resolution by direct crystallization of enantiomer mixtures. Chem Rev 80:215-230.
4. Wood WML. 1997. In: Collins AN, Sheldrake GN, Crosby, editors. Chirality in industry, Vol II. Chichester: John Wiley and Sons: pp 119-155.
5. Challener CA, editors. 2001. Chiral intermediates. New York: John Wiley & Sons Limited: pp 3-109.
6. Beilles S, Cardinael P, Ndzié E, Petit S, Coquerel G. 2001. Preferential crystallisation and comparative crystal growth study between pure enantiomer and racemic mixture of a chiral molecule: 5-ethyl-5-methylhydantoin. Chem Eng Sci 56:2281-2294.
7. Elsner MP, Menendez DF, Muslera EA, Seidel-Morgenstern A. 2005. Experimental study and simplified mathematical description of preferential crystallization. Chirality 17:S183-S195.
8. Wang XJ, Ching CB. 2006. A systematic approach for preferential crystallization of 4-hydroxy-2-pyrrolidone: thermodynamics, kinetics, optimal operation and in-situ monitoring aspects. Chem Eng Sci 61:2406-2417.
9. Lim BG, Ching CB, Tan RBH, Ng SC. 1995. Recovery of (-)-praziquantel from racemic mixtures by continuous chromatography and crystallisation. Chem Eng Sci 50:2289-2298.
10. Lorenz HP, Sheehan P, Seidel-Morgenstern A. 2001. Coupling of simulated moving bed chromatography and fractional crystallisation for efficient enantioseparation. J Chromatogr A 908:201-214.
11. Routhven DM, Ching CB. 1989. Counter-current and simulated counter-current adsorption separation processes. Chem Eng Sci 44:1011-1038.
12. Pedeferri M, Zenoni G, Mazzotti M, Morbidelli M. 1999. Experimental analysis of a chiral separation through simulated moving bed chromatography. Chem Eng Sci 54:3735-3748.
13. Fung KY, Ng KM, Wibowo C. 2005. Synthesis of chromatography- crystallization hybrid separation processes. Ind Eng Chem Res 44:910-921.
14. Schroer JW, Wibowo C, Ng KM. 2001. Synthesis of chiral crystallization processes. AIChE J 47:369-387.
15. Neau SH, Shinwari MK, Hellmuth EW. 1993. Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol. Int J Pharm 99:303-310.
16. Roberts RJ, Rowe RC. 1994. The unit cell dimensions of (R, S)-propranolol hydrochloride - a confirmatory study using data from powder X-ray diffraction. Int J Pharm 109:83-87.
17. Shankland K, Knight KS. 1996. Some observations on the crystal structure of (R, S)-propranolol hydrochloride. Int J Pharm 137:255-259.
18. Li ZJ, Zell MT, Munson EJ, Grant JW. 1999. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies. J Pharm Sci 88:337-346.
19. Wang X, Wang XJ, Ching CB. 2002. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride. Chirality 14:318-324.
20. Bredikhin AA, Savelev DV, Bredikhina ZA, Gubaidullin AT, Litvinov IA. 2003. Crystallization of chiral compounds. 2. Propranolol: free base and hydrochloride. Russ Chem Bull 52:853-861.
21. Elsabee M, Prankerd RJ. 1992. Solid-state properties of drugs. III. Differential scanning calorimetry of chiral drug mixtures existing as racemic solid solutions, racemic mixtures or racemic compounds. Int J Pharm 86:221-230.
22. Ching CB, Fu P, Ng SC, Xu YK. 2000. Effect of mobile phase composition on the separation of propranolol enantiomers using a perphenylcarbamate beta-cyclodextrin bonded chiral stationary phase. J Chromatogr A 898:53-61.
23. Ng SC, Chen L, Zhang LF, Ching CB. 2002. Facile preparative HPLC enantioseparation of racemic drugs using chiral stationary phases based on mono-6(A)-azido-6(A)-deoxy-perphenylcarbamoylated beta-cyclodextrin immobilized on silica gel. Tetrahedron Lett 43:677-681.
24. Barrett P, Glennon B. 2002. Characterizing the metastable zone width and solibility curve using lasentec FBRM and PVM. Chem Eng Res Des 80:799-805.
25. Barthe S, Rousseau RW. 2006. Utilization of focused beam reflectance measurement in the control of crystal size distribution in a batch cooled crystallizer. Chem Eng Techol 29:206-211.
26. Ruf A, Worlitschek J, Mazzotti M. 2000. Modeling and experimental analysis of PSD measurements through FBRM. Particle Particle Syst Charact 17:167-179.
27. Mullin JW. 2001. Crystallization. Oxford: Butterworth-Heinemann.